Conavi Medical to Showcase Imaging System at TCT 2026
The medical company will present its hybrid intravascular technology at the conference in San Diego this November.
Updated on Oct. 15, 2026 in Heart Disease
Live Poll
Do you believe new hybrid imaging technologies improve the standard of care for heart disease patients?
Conavi Medical will debut its FDA-cleared hybrid imaging system at the TCT 2026 conference, taking place at the San Diego Convention Center from October 31 to November 3, 2026. The platform integrates intravascular ultrasound and optical coherence tomography for coronary artery analysis.
Why it matters
By demonstrating this technology to attending specialists, Conavi Medical aims to build clinical relationships and advance its U.S. commercialization efforts. The system provides simultaneous and co-registered views of arteries, which can offer greater diagnostic detail than single-modality imaging.
The system utilizes a single pullback to provide simultaneous and co-registered imaging. Conavi will also participate in 2 specific CRF Imaging Lab physician education sessions during the event.
The players
Conavi Medical
This is a medical technology company focused on developing advanced imaging solutions for cardiovascular procedures.
Dr. Megha Prasad
She is a medical expert scheduled to present findings and case studies regarding hybrid imaging technology at the TCT conference.
The details
The device combines intravascular ultrasound and optical coherence tomography into a single hybrid platform. This integration allows clinicians to receive co-registered views of coronary arteries through one diagnostic pullback, simplifying the imaging process.
Timeline
The TCT 2026 conference begins on October 31, 2026.
Dr. Megha Prasad will deliver a podium case study and an abstract presentation on November 2, 2026.
Conavi Medical participates in two CRF Imaging Lab sessions on November 3, 2026.
The Big Picture
Conavi Medical is aligning its commercial strategy with the CRF Imaging Lab physician education sessions to integrate its new device into established clinical training environments.
This hybrid imaging technology may allow doctors to obtain comprehensive artery data more efficiently during diagnostic procedures. Patients undergoing cardiovascular assessments could benefit from faster procedures that provide simultaneous ultrasound and optical views.
The takeaway
The introduction of hybrid imaging platforms represents a trend toward streamlining complex cardiac diagnostic workflows. Physicians often prioritize systems that combine multiple modalities into a single procedural step to reduce time and complexity.
Further reading
Learn more about the latest innovations in cardiac diagnostic technology in the Heart Disease section.
More information
For more information on the company and its platform, visit the Conavi Medical official corporate website.
Live Poll
Do you believe new hybrid imaging technologies improve the standard of care for heart disease patients?
